VD Exposure in Males Treatment
The treatment of venereal disease in males depends on the underlyig cause, viral or bacterial. Treatment may include antibiotics or an antiviral medication. Sexual partners should also be evaluated by a doctor and treated.
Treatment for venereal disease in males includes:
- Antibiotics for venereal disease:
- Ceftriaxone (Rocephin)
- Cefixime (Suprax)
- Azithromycin (Zithromax)
- Erythromycin ethylsuccinate (E.E.S.)
- Doxycycline (Vibramycin)
- Metronidazole (Flagyl)
- Selection of an antibiotic depends on the type of bacteria that is causing the infection.
- Antivirals for venereal disease:
- Acyclovir (Zovirax)
- Famciclovir (Famvir)
- Valacyclovir (Valtrex)
- Selection of an antiviral depends on the type of virus that is causing the infection.
- Avoid intercourse until after antibiotic treatment is completed.
- Sexual partners should be evaluated by a doctor and treated:
- Re-infection is common if sexual partners are not treated.
- Avoid sexual intercourse until sexual partner is treated.
For more information:
VD Exposure in Males Questions For Doctor
The following are some important questions to ask before and after the treatment of venereal disease in males.
Questions to ask before treatment:
- What are my treatment options?
- What are the risks associated with treatment?
- Am I contagious?
- For how long?
- What are the complications I should watch for?
- How do I avoid passing the infection to others?
- How long will I be on medication?
- What are the potential side effects of my medication?
- Does my medication interact with nonprescription medicines or supplements?
- Should I take my medication with food?
Questions to ask after treatment:
- Do I need to change my diet?
- Are there any medications or supplements I should avoid?
- When can I resume my normal activities?
- When can I return to work?
- What else can I do to reduce my risk for having venereal disease again?
- How often will I need to see my doctor for checkups?
- What local support and other resources are available?
VD Exposure in Males Specialist
Continue to VD Exposure in Males Home Care
- Aledort JE, Hook EW 3rd, Weinstein MC, Goldie SJ. The cost effectiveness of gonorrhea screening in urban emergency departments. Sex Transm Dis. 2005 Jul;32(7):425-36. 
- Dicker LW, Mosure DJ, Berman SM, Levine WC. Gonorrhea prevalence and coinfection with chlamydia in women in the United States, 2000. Sex Transm Dis. 2003 May;30(5):472-6. 
- Mark KE, Gunn RA. Gonorrhea surveillance: estimating epidemiologic and clinical characteristics of reported cases using a sample survey methodology. Sex Transm Dis. 2004 Apr;31(4):215-20. 
- Miller WC, Zenilman JM. Epidemiology of chlamydial infection, gonorrhea, and trichomoniasis in the United States--2005. Infect Dis Clin North Am. 2005 Jun;19(2):281-96. 
- Phipps W, Stanley H, Kohn R, Stansell J, Klausner JD. Syphilis, chlamydia, and gonorrhea screening in HIV-infected patients in primary care, San Francisco, California, 2003. AIDS Patient Care STDS. 2005 Aug;19(8):495-8. 
- Rosenman MB, Kraft SK, Harezlak J, Mahon BE, Katz BP, Wang J, Arno JN. Syphilis testing in association with gonorrhea/chlamydia testing during a syphilis outbreak. Am J Public Health. 2004 Jul;94(7):1124-6.